Skip to content

Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)

Canadian Pulmonary Embolism Diagnosis Study

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00182546
Enrollment
1126
Registered
2005-09-16
Start date
1998-08-31
Completion date
2001-01-31
Last updated
2006-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Venous Thrombosis, Suspected Pulmonary Embolism

Keywords

Pulmonary Embolism, DVT, Venous Thrombosis, D dimer, DD, Thrombosis, Diagnosis

Brief summary

The main objective of the trial is to determine whether D-dimer testing combined with assessment of Pre-Test-Probability (using a standardized clinical model) can be used to markedly simplify the diagnostic process for PE. It may be safe to omit additional diagnostic testing in selected patients with suspected pulmonary embolism who have a negative D-dimer test

Detailed description

To assess the value of the D-dimer in the diagnosis of PE, we had two sub-groups of patients with suspected PE, low and high pre-test probability. Patients could be randomized either to further or no further testing.

Interventions

PROCEDURETwo diagnostic management strategies

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with clinically suspected PE

Exclusion criteria

* Treatment with anticoagulants for greater than 24 hours of performance of D-d * Comorbid condition limiting survival to less than 3 months * Absence of acute symptoms within 7 days prior to presentation * Current pregnancy * Contraindication to contrast (e.g., allergy, renal failure) * Geographic inaccessibility which precludes follow-up * Physician believes patient is inappropriate for study * failure or inability to provide informed consent

Design outcomes

Primary

MeasureTime frame
DVT or PE during 6 months follow-up

Secondary

MeasureTime frame
bleeding

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026